High incidence of low interstitial fluid glucose among type 2 diabetes patients with chronic kidney disease (CKD) despite adhering to appropriate glycated haemoglobin targets—has time come for robust integration of interstitial fluid glucose targets
The CKD cohort has a greater burden of hypoglycaemia despite being treated to similar HbA1c targets. The greater number of nocturnal events warrants safety concern. Interstitial fluid glucose targets should be incorporated into the glycaemic guidelines for T2D patients with CKD.
Authors
- Li Chang Ang (ORCID: https://orcid.org/0000-0002-0415-0394)
- Jason Chon Jun Choo (ORCID: https://orcid.org/0000-0002-8477-0875)
- Su‐Yen Goh (ORCID: https://orcid.org/0000-0003-3758-9982)
- Ming Ming Teh (ORCID: https://orcid.org/0000-0003-4300-0302)
- Kristy Tian (ORCID: https://orcid.org/0009-0009-4465-4333)
- Pratik Choudhary (ORCID: https://orcid.org/0000-0001-7635-4735)
- Yong Mong Bee (ORCID: https://orcid.org/0000-0002-5482-2646)
Institutions
- University of Leicester (GB)
- Singapore General Hospital (SG)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1111/dme.15438
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.36